Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Adipocyte lipin 1 expression associates with human metabolic health and regulates systemic metabolism in mice
Andrew LaPoint, … , Brian N. Finck, Andrew J. Lutkewitte
Andrew LaPoint, … , Brian N. Finck, Andrew J. Lutkewitte
Published October 15, 2024
Citation Information: J Clin Invest. 2024;134(23):e169722. https://doi.org/10.1172/JCI169722.
View: Text | PDF
Research Article Hepatology Metabolism

Adipocyte lipin 1 expression associates with human metabolic health and regulates systemic metabolism in mice

  • Text
  • PDF
Abstract

Dysfunctional adipose tissue is believed to promote the development of hepatic steatosis and systemic insulin resistance, but many of the mechanisms involved are still unclear. Lipin 1 catalyzes the conversion of phosphatidic acid to diacylglycerol, the penultimate step of triglyceride synthesis, which is essential for lipid storage. Herein we found that adipose tissue LPIN1 expression is decreased in people with obesity compared with lean subjects, and low LPIN1 expression correlated with multi-tissue insulin resistance and increased rates of hepatic de novo lipogenesis. Comprehensive metabolic and multiomic phenotyping demonstrated that adipocyte-specific Lpin1–/– mice had a metabolically unhealthy phenotype, including liver and skeletal muscle insulin resistance, hepatic steatosis, increased hepatic de novo lipogenesis, and transcriptomic signatures of metabolically associated steatohepatitis that was exacerbated by high-fat diets. We conclude that adipocyte lipin 1–mediated lipid storage is vital for preserving adipose tissue and systemic metabolic health, and its loss predisposes mice to metabolically associated steatohepatitis.

Authors

Andrew LaPoint, Jason M. Singer, Daniel Ferguson, Trevor M. Shew, M. Katie Renkemeyer, Hector H. Palacios, Rachael L. Field, Sireesha Yerrathota, Roshan Kumari, Mahalakshmi Shankaran, Gordon I. Smith, Jun Yoshino, Mai He, Gary J. Patti, Marc K. Hellerstein, Samuel Klein, Jonathan R. Brestoff, E. Matthew Morris, Brian N. Finck, Andrew J. Lutkewitte

×

Figure 4

Adn-Lpin1–/– mice exhibit systemic insulin resistance on HFD.

Options: View larger image (or click on image) Download as PowerPoint
Adn-Lpin1–/– mice exhibit systemic insulin resistance on HFD.
Eight-week...
Eight-week-old male Adn-Lpin1–/– and WT control mice were fed a 60% HFD for 5 weeks. Five days before clamp, mice were catheterized and allowed to recover. Mice were fasted 5 hours before the clamp procedures as described in detail in Methods. (A) Blood glucose was monitored before and during the clamp and shows that both groups reached and sustained similar steady-state glucose concentrations during the clamp procedure. (B) Exogenous glucose infusion rates (GIR) were measured during the clamp procedure. (C) Endogenous glucose production (rate of appearance [Ra]) was determined from steady-state equations. (D) Whole-body glucose flux (disposal [Rd]) was determined from steady-state equations. (E) High tissue-specific glucose uptake (Rg). (F) Low tissue-specific glucose uptake (Rg). (G) Plasma insulin was measured by radioimmunoassay at –10 minutes for fasting, and 90 and 120 minutes were averaged for clamp values. (H) Ra was plotted against plasma insulin concentrations before and during the clamp. (I) Rd was plotted against plasma insulin concentrations before and during the clamp. (J) Plasma concentrations of non-esterified free fatty acids (NEFA) measured at fasting and clamp and represented as percent suppression from fasting. (K) Plasma concentrations of glycerol measured at fasting and during the clamp and represented as percent suppression from fasting. Data are expressed as means ± SEM, and significance was determined by Student’s t test (A, B, E, F, H, I, J inset, and K inset) or 2-way ANOVA with post hoc Tukey’s multiple-comparison tests where appropriate (C, D, G, J, and K). #P < 0.05 for WT vs. Adn-Lpin1–/– and †P < 0.05 for LFD vs. HFD (n = 5–6).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts